Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging

Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging

Background: We have developed a new radiosensitization treatment called Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II). Using KORTUC II, we performed breast-conserving treatment (BCT) without any surgical procedure for elderly patients with breast cancer in stages I/...

Full description

Bibliographic Details
Main Authors: Shin Yaogawa, Yasuhiro Ogawa, Shiho Morita-Tokuhiro, Akira Tsuzuki, Ryo Akima, Kenji Itoh, Kazuo Morio, Hiroaki Yasunami, Masahide Onogawa, Shinji Kariya, Munenobu Nogami, Akihito Nishioka, Mitsuhiko Miyamura
Format: Article
Language:English
Published: MDPI AG 2015-12-01
Series:Cancers
Subjects:
MRI
breast cancer
KORTUC
hydrogen peroxide
radiosensitizer
sodium hyaluronate
Online Access:http://www.mdpi.com/2072-6694/8/1/1

Internet

http://www.mdpi.com/2072-6694/8/1/1

Similar Items